Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery

ACTIV-3/Therapeutics for Inpatients with COVID-19 (TICO) Study Group

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery'. Together they form a unique fingerprint.

Medicine & Life Sciences